RenovoRx Files Amendment to Beneficial Ownership Statement
Ticker: RNXT · Form: 3/A · Filed: Mar 27, 2026 · CIK: 0001574094
| Field | Detail |
|---|---|
| Company | Renovorx, INC. (RNXT) |
| Form Type | 3/A |
| Filed Date | Mar 27, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership, amendment
TL;DR
RenovoRx filed a 3/A amendment for beneficial ownership as of 02/04/2026.
AI Summary
This is an amendment (3/A) to an initial statement of beneficial ownership of securities filed by RenovoRx, Inc. on February 4, 2026. The filing was accepted on March 27, 2026, and pertains to changes in the beneficial ownership of securities for the company.
Why It Matters
Amendments to beneficial ownership statements can indicate changes in significant holdings by insiders, potentially signaling shifts in confidence or strategy.
Risk Assessment
Risk Level: low — A 3/A filing is an amendment to an initial ownership statement and typically does not represent new material events on its own.
Key Players & Entities
- RenovoRx, Inc. (company) — Issuer of the securities
- 0001574094 (company) — CIK for RenovoRx, Inc.
- 2026-02-04 (date) — Period of report for the ownership statement
- 2026-03-27 (date) — Filing date of the amendment
FAQ
What type of filing is this?
This is a Form 3/A, which is an amendment to an initial statement of beneficial ownership of securities.
Who is the issuer of this filing?
The issuer is RenovoRx, Inc., with CIK 0001574094.
What is the period of report for this filing?
The period of report is February 4, 2026.
When was this amendment filed and accepted?
The filing date and acceptance date for this amendment was March 27, 2026.
What is the SIC code for RenovoRx, Inc.?
The SIC code for RenovoRx, Inc. is 2834, which falls under Pharmaceutical Preparations.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 9.1 · Accepted 2026-03-27 07:30:09
Filing Documents
- ownership.html (3/A)
- ownership.xml (3/A) — 3KB
- 0001493152-26-013082.txt ( ) — 4KB
From the Filing
SEC FORM 3/A SEC Form 3 FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5 1. Name and Address of Reporting Person * VOLL MARK (Last) (First) (Middle) C/O RENOVORX, INC. 2570 W EL CAMINO REAL, SUITE 320 (Street) MOUNTAIN VIEW CALIFORNIA 94040 (City) (State) (Zip) UNITED STATES (Country) 2. Date of Event Requiring Statement (Month/Day/Year) 02/04/2026 3. Issuer Name and Ticker or Trading Symbol RenovoRx, Inc. [ RNXT ] 3a. Foreign Trading Symbol 5. If Amendment, Date of Original Filed (Month/Day/Year) 03/24/2026 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Financial Officer 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person Table I - Non-Derivative Securities Beneficially Owned 1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 25,000 (1) D Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. The securities were purchased in the open market prior to the Reporting Person's appointment as Chief Financial Officer of the Issuer. Remarks: The Reporting Person is filing this amendment to the Form 3 originally filed on March 24, 2026, to reflect the Reporting Person's correct title as Chief Financial Officer, rather than Chief Executive Officer as inadvertently reported in Footnote 1. /s/ Mark Voll 03/27/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 3: SEC 1473 (03-26)